The results showed that CDCA3 demonstrated a significantly high expression in the whole samples, and in the matched pairs, the mRNA level of CDCA3 was also higher in bladder urothelial carcinoma tissues than in normal tissues (Fig. 1 a, b). The gene discussed is CDCA3; the disease is bladder transitional cell carcinoma.